Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 775

1.

Menopausal hormone replacement therapy and risk of ovarian cancer.

Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C.

JAMA. 2002 Jul 17;288(3):334-41. Erratum in: JAMA 2002 Nov 27;288(20):2544.

PMID:
12117398
[PubMed - indexed for MEDLINE]
2.

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R.

JAMA. 2000 Jan 26;283(4):485-91. Erratum in: JAMA 2000 Nov 22-29;284(20):2597.

PMID:
10659874
[PubMed - indexed for MEDLINE]
3.

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.

Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P.

J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405.

PMID:
17018786
[PubMed - indexed for MEDLINE]
Free Article
4.

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ.

JAMA. 2001 Mar 21;285(11):1460-5.

PMID:
11255422
[PubMed - indexed for MEDLINE]
5.

Hormone therapy and ovarian cancer.

Mørch LS, Løkkegaard E, Andreasen AH, Krüger-Kjaer S, Lidegaard O.

JAMA. 2009 Jul 15;302(3):298-305. doi: 10.1001/jama.2009.1052.

PMID:
19602689
[PubMed - indexed for MEDLINE]
6.

Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.

Lacey JV Jr, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1724-31.

PMID:
16030108
[PubMed - indexed for MEDLINE]
Free Article
7.

Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.

Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA.

JAMA. 1995 Jul 12;274(2):137-42.

PMID:
7596001
[PubMed - indexed for MEDLINE]
8.

Postmenopausal estrogen and progestin use in relation to breast cancer risk.

Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600.

PMID:
12101105
[PubMed - indexed for MEDLINE]
Free Article
9.

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR.

JAMA. 2003 Jun 25;289(24):3254-63.

PMID:
12824206
[PubMed - indexed for MEDLINE]
10.

Risk of endometrial cancer following estrogen replacement with and without progestins.

Weiderpass E, Adami HO, Baron JA, Magnusson C, Bergström R, Lindgren A, Correia N, Persson I.

J Natl Cancer Inst. 1999 Jul 7;91(13):1131-7.

PMID:
10393721
[PubMed - indexed for MEDLINE]
Free Article
11.

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

Persson I, Yuen J, Bergkvist L, Schairer C.

Int J Cancer. 1996 Jul 29;67(3):327-32.

PMID:
8707404
[PubMed - indexed for MEDLINE]
12.

Postmenopausal hormone use and incident ovarian cancer: Associations differ by regimen.

Hildebrand JS, Gapstur SM, Feigelson HS, Teras LR, Thun MJ, Patel AV.

Int J Cancer. 2010 Dec 15;127(12):2928-35. doi: 10.1002/ijc.25515.

PMID:
21351271
[PubMed - indexed for MEDLINE]
13.

Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study.

Colditz GA, Stampfer MJ, Willett WC, Hunter DJ, Manson JE, Hennekens CH, Rosner BA, Speizer FE.

Cancer Causes Control. 1992 Sep;3(5):433-9.

PMID:
1525324
[PubMed - indexed for MEDLINE]
14.

Estrogen-progestin replacement therapy and endometrial cancer.

Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM.

J Natl Cancer Inst. 1997 Aug 6;89(15):1110-6.

PMID:
9262248
[PubMed - indexed for MEDLINE]
Free Article
15.

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.

Ross RK, Paganini-Hill A, Wan PC, Pike MC.

J Natl Cancer Inst. 2000 Feb 16;92(4):328-32.

PMID:
10675382
[PubMed - indexed for MEDLINE]
Free Article
16.

Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.

Lacey JV Jr, Leitzmann MF, Chang SC, Mouw T, Hollenbeck AR, Schatzkin A, Brinton LA.

Cancer. 2007 Apr 1;109(7):1303-11. Erratum in: Cancer. 2007 Aug 15;110(4):937.

PMID:
17315161
[PubMed - indexed for MEDLINE]
Free Article
17.

Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).

Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR, Hoover RN.

Cancer Causes Control. 1994 Nov;5(6):491-500.

PMID:
7827235
[PubMed - indexed for MEDLINE]
18.

Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.

Glud E, Kjaer SK, Thomsen BL, Høgdall C, Christensen L, Høgdall E, Bock JE, Blaakaer J.

Arch Intern Med. 2004 Nov 8;164(20):2253-9.

PMID:
15534163
[PubMed - indexed for MEDLINE]
19.

Postmenopausal hormone replacement therapy: scientific review.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

JAMA. 2002 Aug 21;288(7):872-81. Review.

PMID:
12186605
[PubMed - indexed for MEDLINE]
20.

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML.

JAMA. 2007 Apr 4;297(13):1465-77. Erratum in: JAMA. 2008 Mar 26;299(12):1426.

PMID:
17405972
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk